China, Japan To Research Cheaper Way To Mass Produce Antiviral Tamiflu
This article was originally published in PharmAsia News
Executive Summary
Japan and China have begun joint research aimed at mass producing Tamiflu (oseltamivir), Roche's antiviral, at a lower cost